Breast cancer in carriers of BRCA1 and BRCA2 mutations:: Tackling a molecular and clinical conundrum

被引：11

作者：

Haber, DA ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1999年 / 17卷 / 11期

关键词：

D O I：

10.1200/JCO.1999.17.11.3367

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3367 / 3370

页数：4

共 35 条

[1] Transcriptional activation by BRCA1 [J].

Chapman, MS ;

Verma, IM .

NATURE, 1996, 382 (6593) :678-679

[2]

Chodosh LA, 1999, CANCER RES, V59, p1765S

[3] BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer [J].

Couch, FJ ;

DeShano, ML ;

Blackwood, MA ;

Calzone, K ;

Stopfer, J ;

Campeau, L ;

Ganguly, A ;

Rebbeck, T ;

Weber, BL ;

Jablon, L ;

Cobleigh, MA ;

Hoskins, K ;

Garber, JE .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (20) :1409-1415

[4] The effect of raloxifene on risk of breast cancer in postmenopausal women - Results from the MORE randomized trial [J].

Cummings, SR ;

Eckert, S ;

Krueger, KA ;

Grady, D ;

Powles, TJ ;

Cauley, JA ;

Norton, L ;

Nickelsen, T ;

Bjarnason, NH ;

Morrow, M ;

Lippman, ME ;

Black, D ;

Glusman, JE ;

Costa, A ;

Jordan, VC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (23) :2189-2197

[5] BRCA1 and BRCA2 testing:: Weighing the demand against the benefits [J].

Devilee, P .

AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (04) :943-948

[6] Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].

Fisher, B ;

Costantino, JP ;

Wickerham, DL ;

Redmond, CK ;

Kavanah, M ;

Cronin, WM ;

Vogel, V ;

Robidoux, A ;

Dimitrov, N ;

Atkins, J ;

Daly, M ;

Wieand, S ;

Tan-Chiu, E ;

Ford, L ;

Wolmark, N .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388

[7] Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer [J].

FitzGerald, MG ;

MacDonald, DJ ;

Krainer, M ;

Hoover, I ;

ONeil, E ;

Unsal, H ;

SilvaArrieto, S ;

Finkelstein, DM ;

BeerRomero, P ;

Englert, C ;

Sgroi, DC ;

Smith, BL ;

Younger, JW ;

Garber, JE ;

Duda, RB ;

Mayzel, KA ;

Isselbacher, KJ ;

Friend, SH ;

Haber, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :143-149

[8] RISKS OF CANCER IN BRCA1-MUTATION CARRIERS [J].

FORD, D ;

EASTON, DF ;

BISHOP, DT ;

NAROD, SA ;

GOLDGAR, DE ;

HAITES, N ;

MILNER, B ;

ALLAN, L ;

PONDER, BAJ ;

PETO, J ;

SMITH, S ;

STRATTON, M ;

LENOIR, GM ;

FEUNTEUN, J ;

LYNCH, H ;

ARASON, A ;

BARKARDOTTIR, R ;

EGILSSON, V ;

BLACK, DM ;

KELSELL, D ;

SPURR, N ;

DEVILEE, P ;

CORNELISSE, CJ ;

VARSEN, H ;

BIRCH, JM ;

SKOLNICK, M ;

SANTIBANEZKOREF, MS ;

TEARE, D ;

STEEL, M ;

PORTER, D ;

COHEN, BB ;

CAROTHERS, A ;

SMYTH, E ;

WEBER, B ;

NEWBOLD, B ;

BOEHNKE, M ;

COLLINS, FS ;

CANNONALBRIGHT, LA ;

GOLDGAR, D .

LANCET, 1994, 343 (8899) :692-695

[9] Clinical potential of new antiestrogens [J].

Gradishar, WJ ;

Jordan, VC .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) :840-852

[10] Partial rescue of Brca1(5-6) early embryonic lethality by p53 or p21 null mutation [J].

Hakem, R ;

delaPompa, JL ;

Eli, A ;

Potter, J ;

Mak, TW .

NATURE GENETICS, 1997, 16 (03) :298-302

← 1 2 3 4 →